Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Dec;25(6):831-841.
doi: 10.1007/s11102-022-01266-4. Epub 2022 Aug 3.

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

Affiliations
Multicenter Study

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

Sabrina Chiloiro et al. Pituitary. 2022 Dec.

Abstract

Introduction: Acromegaly is a chronic disease with systemic complications. Disease onset is insidious and consequently typically burdened by diagnostic delay. A longer diagnostic delay induces more frequently cardiovascular, respiratory, metabolic, neuropsychiatric and musculoskeletal comorbidities. No data are available on the effect of diagnostic delay on skeletal fragility. We aimed to evaluate the effect of diagnostic delay on the frequency of incident and prevalent of vertebral fractures (i-VFs and p-VFs) in a large cohort of acromegaly patients.

Patients and methods: A longitudinal, retrospective and multicenter study was conducted on 172 acromegaly patients.

Results: Median diagnostic delay and duration of follow-up were respectively 10 years (IQR: 6) and 10 years (IQR: 8). P-VFs were observed in 18.6% and i-VFs occurred in 34.3% of patients. The median estimated diagnostic delay was longer in patients with i-VFs (median: 11 years, IQR: 3), in comparison to those without i-VFs (median: 8 years, IQR: 7; p = 0.02). Age at acromegaly diagnosis and at last follow-up were higher in patients with i-VFs, with respect to those without i-VFs. The age at acromegaly diagnosis was positively associated with the diagnostic delay (p < 0.001, r = 0.216). A longer history of active acromegaly was associated with a high frequency of i-VFs (p = 0.03). The logistic regression confirmed that patients with a diagnostic delay > 10 years had 1.5-folds increased risk of developing i-VFs (OR: 1.5; 95%CI: 1.1-2; p = 0.017).

Conclusion: Our data showed that the diagnostic delay in acromegaly has a significant impact on VF risk, further supporting the clinical relevance of an early acromegaly diagnosis.

Keywords: GH; GH secreting adenoma; IGF-1; Osteomalacia; Skeletal fragility; Vertebral fractures.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this paper.

Figures

Fig. 1
Fig. 1
Histogram showing the percentage of incident vertebral fractures according to diagnostic delay. Univariate analysis
Fig. 2
Fig. 2
Roc Curve. The area under the ROC curve developed for the month of diagnostic delay in patients who developed incident vertebral fractures was was 0.68 (95% CI 0.5–0.82; p = 0.04), as showed in Fig. 2. Optimal cut-off was identified at 10 years (specificity: 90.9% sensitivity: 74%)
Fig. 3
Fig. 3
Scatter plot correlating in a the age of patients at the acromegaly diagnosis and at the time of the diagnosis of incident VFs (p < 0.001, r = 0.841) and in b the age of patients at the acromegaly diagnosis and the age of patients at last follow-up (p < 0.001, r = 0.951)
Fig. 4
Fig. 4
Scatter plot correlating age at acromegaly diagnosis and diagnostic delay (p < 0.001, r = 0.216)

Similar articles

Cited by

References

    1. Kasuki L, Rocha PDS, Lamback EB, Gadelha MR. Determinants of morbidities and mortality in acromegaly. Arch Endocrinol Metab. 2019;63(6):630–637. doi: 10.20945/2359-3997000000193. - DOI - PMC - PubMed
    1. Chiloiro S, Mirra F, Federico D, Giampietro A, Visconti F, Rossi L, Pontecorvi A, De Marinis L, Bianchi A. The role of growth hormone receptor isoforms and their effects in bone metabolism and skeletal fragility. Protein Pept Lett. 2020;27(12):1260–1267. doi: 10.2174/0929866527666200616151105. - DOI - PubMed
    1. Kužma M, Killinger Z, Jackuliak P, Vaňuga P, Hans D, Binkley N, Payer J. Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score. Physiol Res. 2019;68(2):S121–S129. doi: 10.33549/physiolres.934303. - DOI - PubMed
    1. Bima C, Chiloiro S, Mormando M, Piacentini S, Bracaccia E, Giampietro A, Tartaglione L, Bianchi A, De Marinis L. Understanding the effect of acromegaly on the human skeleton. Expert Rev Endocrinol Metab. 2016;11(3):263–270. doi: 10.1080/17446651.2016.1179108. - DOI - PubMed
    1. Giustina A. Acromegaly and vertebral fractures: facts and questions. Trends Endocrinol Metab. 2020;31(4):274–275. doi: 10.1016/j.tem.2020.01.011. - DOI - PubMed

Publication types

LinkOut - more resources